French pharmaceutical giant Sanofi and American drugmaker Regeneron said Monday they have started clinical trials for a new drug in patients hospitalised with severe COVID-19 infections.
In a statement they said phase 2 and 3 trials were under way for Kevzara, an immunosuppressor.
Regeneron will trial in the United States, while Sanofi plans trials initially in Italy, particularly hard hit by the novel coronavirus pandemic.
Has anyone had a Spirometry test recently?
New and Saying Hello after COVID
Lung Function Test & Covid
Lung Cancer Treatment
Are nasties still partying in my lungs? And flu and booster jabs.
